NFKB1 and colitis: Baicalin ameliorated TNBS-induced colitis injury by suppressing TLR4 signaling in a concentration-dependent manner, inhibiting NF-κB activation and limiting the inflammatory response, such as ICAM-1, MCP-1, Cox-2, TNF-α, IL-1β and IL-6 [59].